Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Archives
Print | Email | Share | Comments (0)

Transplanted Islets Survive in Mismatched Donor - Bone Marrow Used

Jan 7, 2000

Researchers have successfully transplanted primate pancreatic islets into a mismatched diabetic primate without the need for long-term administration of anti-rejection drugs.

BioTransplant Incorporated of Charleston, Massachussetts, is saying the procedure may have eventual practical application in pig-to-human xeno-transplantation

BioTransplant announced the process is done using a multi-step bone marrow transplantation procedure. It claims this induces tolerance that does not involve destruction of the recipient's immune system.

Tatsuo Kawai, MD, a Massachusetts General Hospital transplant surgeon, speaking at the Transplant 2000 convention in Chicago, reported that a primate model's type 1 diabetes was completely reversed by the transplant procedure. The primate's diabetes remained reversed at more than 230 days after transplantation.

According to BioTransplant, researchers have previously demonstrated in primates and other animal models that transplantation of donor kidneys or hearts can be accomplished in mismatched recipients without the need for long-term anti-rejection drugs.

"This work has the potential to achieve the ultimate goal of transplantation, long-term acceptance of foreign cell, tissue and organ grafts, without the toxicity associated with long-term use of immunosuppressive drugs," says Elliot Lebowitz, BioTransplant's president and CEO.

The research was supported by grants from both BioTrans-plant and the National Institutes of Health.

For more information, contact Lebowitz at 617-241-5200.


Categories: Diabetes, Diabetes, Islet & Pancreas Transplant, Type 1 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Jan 7, 2000

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.